Parallel Session F: Challenges and Development of Rare Disease Management and Policy

  1. Rare disease is not rare
  2. Brian CHUNG, Hong Kong Genome Institute

  3. Importance of Patient Registry for clinical advancement
  4. Edwin CHAN, The Chinese University of Hong Kong

  5. Confession from the family with Rare disease
  6. Rebecca YUEN, Tuberous Sclerosis Complex Association of Hong Kong

  7. Speak for us, a new value for public policy
  8. Joephy W. Y. CHAN, Legislative Council

  9. Improving the Diagnosis of Rare Genetic Diseases through CoGenesis: An Integrated Bioinformatics Platform
  10. Allen YU, Aldrin YIM, Codex Genetics Limited

  11. R&D for new drugs
  12. Ivan LEE, Lee’s Pharmaceutical (HK) Limited